In Vivo Determination of Muscarinic Acetylcholine Receptor Availability in Schizophrenia

American Journal of Psychiatry - United States
doi 10.1176/appi.ajp.160.1.118
Full Text
Abstract

Available in full text

Date
Authors
Publisher

American Psychiatric Association Publishing

Related search

Reduced Brain Cannabinoid Receptor Availability in Schizophrenia

Biological Psychiatry
Biological Psychiatry
2016English

Solubilization of the Muscarinic Acetylcholine Receptor by Sodium Cholate: Stabilization of the Receptor by Muscarinic Ligands

Biomedical Research
BiochemistryMedicineGeneticsMolecular Biology
1982English

Muscarinic Acetylcholine Receptor Immunoreactivity in the Amygdala—II. Fear-Induced Plasticity

Neuroscience
Neuroscience
1996English

In Vivo Characterization of Vasodilating Muscarinic-Receptor Subtypes in Humans

Circulation Research
Cardiovascular MedicinePhysiologyCardiology
1994English

Expression of Muscarinic Acetylcholine and Dopamine Receptor mRNAs in Rat Basal Ganglia.

Proceedings of the National Academy of Sciences of the United States of America
Multidisciplinary
1990English

Ligand-Binding Propeties of the Muscarinic Acetylcholine Receptor in Mouse Neuroblastoma Cells

Biochemical Journal
BiochemistryCell BiologyMolecular Biology
1978English

Adrenergic Receptor Β2 (ADRB2); ADRB3; Muscarinic Acetylcholine Receptor M1 (CHRM1; HM1)

Science-Business eXchange
2013English

Allosteric Modulation of the M1 Muscarinic Acetylcholine Receptor: Improving Cognition and a Potential Treatment for Schizophrenia and Alzheimer's Disease

Drug Discovery Today
Drug DiscoveryPharmacology
2013English

An Investigation of the Factors That Regulate Muscarinic Receptor Expression in Schizophrenia

Schizophrenia Research
PsychiatryMental HealthBiological Psychiatry
2014English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy